share_log

ABA Chemicals (SZSE:300261) Is Carrying A Fair Bit Of Debt

ABA Chemicals (SZSE:300261) Is Carrying A Fair Bit Of Debt

ABA Chemicals(深圳證券交易所代碼:300261)揹負着相當多的債務
Simply Wall St ·  03/26 20:18

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. Importantly, ABA Chemicals Corporation (SZSE:300261) does carry debt. But the more important question is: how much risk is that debt creating?

傳奇基金經理李露(由查理·芒格支持)曾經說過:“最大的投資風險不是價格的波動,而是你是否會遭受永久的資本損失。”當你檢查公司的資產負債表的風險時,考慮它的資產負債表是很自然的,因爲企業倒閉時通常會涉及債務。重要的是,ABA化學公司(深圳證券交易所代碼:300261)確實有債務。但更重要的問題是:這筆債務會帶來多大的風險?

When Is Debt A Problem?

債務何時會成爲問題?

Debt and other liabilities become risky for a business when it cannot easily fulfill those obligations, either with free cash flow or by raising capital at an attractive price. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Having said that, the most common situation is where a company manages its debt reasonably well - and to its own advantage. The first step when considering a company's debt levels is to consider its cash and debt together.

當企業無法通過自由現金流或以有吸引力的價格籌集資金來輕鬆履行這些義務時,債務和其他負債就會變得有風險。歸根結底,如果公司無法履行償還債務的法律義務,股東可能會一無所獲地離開。儘管這種情況並不常見,但我們經常看到負債累累的公司永久稀釋股東,因爲貸款人迫使他們以不良价格籌集資金。話雖如此,最常見的情況是公司合理地管理其債務,而且對自己有利。考慮公司的債務水平的第一步是同時考慮其現金和債務。

How Much Debt Does ABA Chemicals Carry?

ABA Chemicals 揹負了多少債務?

The image below, which you can click on for greater detail, shows that at September 2023 ABA Chemicals had debt of CN¥985.2m, up from CN¥856.1m in one year. On the flip side, it has CN¥395.7m in cash leading to net debt of about CN¥589.5m.

您可以點擊下圖查看更多詳情,該圖片顯示,截至2023年9月,ABA Chemicals的債務爲9.852億元人民幣,高於一年內的8.561億元人民幣。另一方面,它擁有3.957億元的現金,淨負債約爲5.895億元人民幣。

debt-equity-history-analysis
SZSE:300261 Debt to Equity History March 27th 2024
SZSE: 300261 2024 年 3 月 27 日債務與股權比率的歷史記錄

A Look At ABA Chemicals' Liabilities

看看ABA Chemicals的負債

The latest balance sheet data shows that ABA Chemicals had liabilities of CN¥1.27b due within a year, and liabilities of CN¥356.9m falling due after that. Offsetting this, it had CN¥395.7m in cash and CN¥765.8m in receivables that were due within 12 months. So it has liabilities totalling CN¥463.7m more than its cash and near-term receivables, combined.

最新的資產負債表數據顯示,ABA Chemicals的負債爲12.7億元人民幣,之後到期的負債爲3.569億元人民幣。與此相抵消的是,它有3.957億元的現金和7.658億元人民幣的應收賬款將在12個月內到期。因此,它的負債總額比現金和短期應收賬款的總和多出4.637億元人民幣。

Given ABA Chemicals has a market capitalization of CN¥5.52b, it's hard to believe these liabilities pose much threat. But there are sufficient liabilities that we would certainly recommend shareholders continue to monitor the balance sheet, going forward. There's no doubt that we learn most about debt from the balance sheet. But you can't view debt in total isolation; since ABA Chemicals will need earnings to service that debt. So when considering debt, it's definitely worth looking at the earnings trend. Click here for an interactive snapshot.

鑑於ABA Chemicals的市值爲55.2億元人民幣,很難相信這些負債會構成很大的威脅。但是,有足夠的負債,我們肯定會建議股東今後繼續監督資產負債表。毫無疑問,我們從資產負債表中學到的關於債務的知識最多。但是你不能完全孤立地看待債務;因爲ABA Chemicals需要收益來償還債務。因此,在考慮債務時,絕對值得一看收益趨勢。單擊此處查看交互式快照。

In the last year ABA Chemicals had a loss before interest and tax, and actually shrunk its revenue by 31%, to CN¥1.4b. That makes us nervous, to say the least.

去年,ABA Chemicals在利息和稅前出現虧損,實際收入減少了31%,至14億元人民幣。至少可以說,這讓我們感到緊張。

Caveat Emptor

Caveat Emptor

While ABA Chemicals's falling revenue is about as heartwarming as a wet blanket, arguably its earnings before interest and tax (EBIT) loss is even less appealing. Indeed, it lost CN¥60m at the EBIT level. Considering that alongside the liabilities mentioned above does not give us much confidence that company should be using so much debt. Quite frankly we think the balance sheet is far from match-fit, although it could be improved with time. We would feel better if it turned its trailing twelve month loss of CN¥80m into a profit. So we do think this stock is quite risky. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. For example, we've discovered 2 warning signs for ABA Chemicals (1 is a bit unpleasant!) that you should be aware of before investing here.

儘管ABA Chemicals收入的下降像溼毯一樣令人心動,但可以說,其利息和稅前收益(EBIT)虧損的吸引力更小。事實上,它在息稅前利潤水平上損失了6000萬元人民幣。考慮到除了上述負債外,我們對公司應該使用如此多的債務沒有太大的信心。坦率地說,我們認爲資產負債表遠非匹配,儘管可以隨着時間的推移而改善。如果它將過去十二個月的8000萬元人民幣的虧損轉化爲利潤,我們會感覺更好。因此,我們確實認爲這隻股票風險很大。在分析債務水平時,資產負債表是顯而易見的起點。但歸根結底,每家公司都可以控制資產負債表之外存在的風險。例如,我們發現了 ABA Chemicals 的 2 個警告標誌(1 個有點不愉快!)在這裏投資之前,您應該注意這一點。

If, after all that, you're more interested in a fast growing company with a rock-solid balance sheet, then check out our list of net cash growth stocks without delay.

畢竟,如果你對一家資產負債表堅如磐石的快速成長型公司更感興趣,那麼請立即查看我們的淨現金增長股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論